The generic pharmaceutical market is saturated and just like the rest of the generic pharmaceutical world, prices are down causing the company to have to re-think its strategy. Times are tough, but they are trying. They offer a product on the expensive end of the industry which is not ideal with hospital spending restraints on healthcare spending. Your options for career development are limited, many people have not moved from their roles after many years. The company is currently on a tight budget, holiday parties are a thing of the past, and merit increases are limited to 2%.